About LifePoint Health (NASDAQ:LPNT)
.gif "LifePoint Health logo")
LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities. Its services include general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation services and pediatric services, and in some of its hospitals, the Company offers specialized services, such as open-heart surgery, skilled nursing, psychiatric care and neuro-surgery. It provides outpatient services, such as same-day surgery, laboratory, x-ray, respiratory therapy, imaging, sports medicine and lithotripsy.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services
- Sub-Industry: Health Care Facilities
- Symbol: NASDAQ:LPNT
- CUSIP: 53219L10
- Web: www.lifepointhealth.net
Capitalization:- Market Cap: $2.25051 billion
- Outstanding Shares: 40,116,000
Average Prices:- 50 Day Moving Avg: $56.57
- 200 Day Moving Avg: $60.84
- 52 Week Range: $50.60 - $70.95
P/E:- Trailing P/E Ratio: 12.95
- Foreward P/E Ratio: 13.00
- P/E Growth: 1.44
Sales & Book Value:- Annual Revenue: $6.42 billion
- Price / Sales: 0.36
- Book Value: $56.81 per share
- Price / Book: 1.02
Profitability:- EBITDA: $760.4 million
- Net Margins: 2.61%
- Return on Equity: 7.40%
- Return on Assets: 2.66%
Debt:- Debt-to-Equity Ratio: 1.24%
- Current Ratio: 1.82%
- Quick Ratio: 1.60%
Misc:- Average Volume: 410,571 shs.
- Beta: 0.84
- Short Ratio: 13.42
Frequently Asked Questions for LifePoint Health (NASDAQ:LPNT)
What is LifePoint Health's stock symbol?
LifePoint Health trades on the NASDAQ under the ticker symbol "LPNT."
How were LifePoint Health's earnings last quarter?
LifePoint Health, Inc. (NASDAQ:LPNT) released its quarterly earnings data on Tuesday, August, 1st. The company reported $0.96 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.06. The company earned $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. LifePoint Health's revenue was up .2% compared to the same quarter last year. During the same period last year, the business earned $0.69 earnings per share. View LifePoint Health's Earnings History.
When will LifePoint Health make its next earnings announcement?
What guidance has LifePoint Health issued on next quarter's earnings?
LifePoint Health issued an update on its FY17 earnings guidance on Tuesday, August, 1st. The company provided earnings per share guidance of $3.92-$4.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.19. The company issued revenue guidance of $6.425-$6.500 billion, compared to the consensus revenue estimate of $6.55 billion.
Where is LifePoint Health's stock going? Where will LifePoint Health's stock price be in 2017?
15 equities research analysts have issued 12-month price objectives for LifePoint Health's stock. Their predictions range from $59.00 to $77.00. On average, they anticipate LifePoint Health's stock price to reach $64.92 in the next twelve months. View Analyst Ratings for LifePoint Health.
What are analysts saying about LifePoint Health stock?
Here are some recent quotes from research analysts about LifePoint Health stock:
- 1. According to Zacks Investment Research, "LifePoint Health’s stock has underperformed the industry in last three months. The company is faced with increasing expenses which has outpaced revenue growth thereby squeezing operating margins. The company is suffering from low patient admissions. High bad debt is another concern. Following second-quarter results, the company trimmed its 2017 guidance on a challenging volume environment and weak revenue growth. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2.9% downward over the last 60 days." (10/3/2017)
- 2. Cantor Fitzgerald analysts commented, "We are reiterating our neutral rating and $55 price target, adjusting our 2017 adjusted EPS estimates and introducing 2018 estimates. Margins continue to be weak, and although we expect them to be relatively stable in 2017-18, our earnings outlook is generally lower than consensus and management's 2017 outlook. In our view, LPNT's acquisition strategy and joint venture have added some promising properties, but they are weighing on earnings as volumes remain disappointing." (2/21/2017)
Who are some of LifePoint Health's key competitors?
Some companies that are related to LifePoint Health include Mednax (MD), Acadia Healthcare Company (ACHC), Chemed Corp. (CHE), Select Medical Holdings Corporation (SEM), Udg Healthcare PLC (UDG), HMS Holdings Corp (HMSY), Tenet Healthcare Corporation (THC), China Cord Blood Corporation (CO), HealthStream (HSTM), The Providence Service (PRSC), Community Health Systems (CYH), Kindred Healthcare (KND), Georgia Healthcare Group PLC (GHG), American Renal Associates Holdings (ARA), Cambian Group PLC (CMBN), Concord Medical Services Hldg Ltd (CCM), Nobilis Health Corp (HLTH) and The Joint Corp. (JYNT).
Who are LifePoint Health's key executives?
LifePoint Health's management team includes the folowing people:
- William F. Carpenter III, Chairman of the Board, Chief Executive Officer
- David M. Dill, President, Chief Operating Officer
- Michael S. Coggin, Chief Financial Officer, Executive Vice President, Chief Accounting Officer
- Victor Giovanetti, President — Eastern Group
- Robert N. Klein, President — Western Group
- R. Scott Raplee, President - Central Group
- Melissa O. Waddey, President - Ambulatory and Operations Services
- John P. Bumpus, Executive Vice President, Chief Administrative Officer
- Jennifer C. Peters, Senior Vice President, General Counsel
- Russell L. Holman M.D., Chief Medical Officer
Who owns LifePoint Health stock?
LifePoint Health's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Diamond Hill Capital Management Inc. (4.01%) and Mutual of America Capital Management LLC (0.08%). Company insiders that own LifePoint Health stock include David M Dill, Gregory T Bier, John E D D S Maupin Jr, John P Bumpus, Richard H Evans and William F Carpenter III. View Institutional Ownership Trends for LifePoint Health.
Who sold LifePoint Health stock? Who is selling LifePoint Health stock?
LifePoint Health's stock was sold by a variety of institutional investors in the last quarter, including Diamond Hill Capital Management Inc. and Mutual of America Capital Management LLC. Company insiders that have sold LifePoint Health stock in the last year include David M Dill, John P Bumpus, Richard H Evans and William F Carpenter III. View Insider Buying and Selling for LifePoint Health.
How do I buy LifePoint Health stock?
Shares of LifePoint Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is LifePoint Health's stock price today?
One share of LifePoint Health stock can currently be purchased for approximately $57.85.
MarketBeat Community Rating for LifePoint Health (NASDAQ LPNT)MarketBeat's community ratings are surveys of what our community members think about LifePoint Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for LifePoint Health (NASDAQ:LPNT) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Sell Ratings, 10 Hold Ratings, 3 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.07) |
| Consensus Price Target: | $64.92 (12.22% upside) |
Consensus Price Target History for LifePoint Health (NASDAQ:LPNT)
Analysts' Ratings History for LifePoint Health (NASDAQ:LPNT)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 10/16/2017 | BMO Capital Markets | Initiated Coverage | Market Perform | $59.00 | N/A |  |
| 10/12/2017 | SunTrust Banks, Inc. | Set Price Target | Hold | $60.00 | N/A | |
| 10/12/2017 | Robert W. Baird | Set Price Target | Buy | $69.00 | N/A | |
| 10/4/2017 | Piper Jaffray Companies | Reiterated Rating | Hold | $66.00 | Medium | |
| 7/5/2017 | Royal Bank Of Canada | Reiterated Rating | Buy | $77.00 | High | |
| 6/6/2017 | Leerink Swann | Upgrade | Market Perform -> Outperform | $73.00 -> $74.00 | Low | |
| 6/6/2017 | Morgan Stanley | Initiated Coverage | Equal -> Equal Weight | $65.00 | Medium | |
| 5/1/2017 | Barclays PLC | Boost Price Target | Equal Weight | $58.00 -> $60.00 | Low | |
| 4/4/2017 | Deutsche Bank AG | Initiated Coverage | Hold -> Hold | $68.00 | Low | |
| 3/27/2017 | Mizuho | Boost Price Target | Neutral -> Neutral | $57.00 -> $62.00 | Medium | |
| 2/21/2017 | Cantor Fitzgerald | Reiterated Rating | Neutral | | N/A | |
| 11/11/2016 | Credit Suisse Group | Downgrade | Outperform -> Neutral | $70.00 -> $60.00 | N/A | |
| 11/9/2016 | Avondale Partners | Downgrade | Outperform -> Market Perform | | N/A | |
| 11/9/2016 | Bank of America Corporation | Downgrade | Neutral -> Underperform | $66.00 -> $59.00 | N/A | |
| 10/25/2016 | Wolfe Research | Initiated Coverage | Underperform | | N/A | |
| 9/30/2016 | Citigroup Inc. | Reiterated Rating | Buy | $68.00 | N/A | |
| 8/2/2016 | Raymond James Financial, Inc. | Lower Price Target | Outperform | $75.00 -> $65.00 | N/A | |
| 8/1/2016 | Wedbush | Reiterated Rating | Neutral | $80.00 -> $66.00 | N/A | |
| 5/16/2016 | Sterne Agee CRT | Reiterated Rating | Buy | | N/A | |
| 2/19/2016 | Goldman Sachs Group, Inc. (The) | Lower Price Target | Neutral | $81.00 -> $77.00 | N/A | |
| 11/2/2015 | Oppenheimer Holdings, Inc. | Reiterated Rating | Market Perform | | N/A | |
(Data available from 10/20/2015 forward)
Earnings History for LifePoint Health (NASDAQ:LPNT)Earnings History by Quarter for LifePoint Health (NASDAQ LPNT)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/27/2017 | | $0.98 | | | | | N/A | |
| 8/1/2017 | Q2 2017 | $0.90 | $0.96 | $1.64 billion | $1.59 billion | View | Listen | |
| 4/28/2017 | Q1 2017 | $1.01 | $1.07 | $1.64 billion | $1.63 billion | View | N/A | |
| 2/17/2017 | Q4 2016 | $1.07 | $1.09 | $1.63 billion | $1.61 billion | View | N/A | |
| 10/28/2016 | Q316 | $0.84 | $0.94 | $1.59 billion | $1.59 billion | View | Listen | |
| 7/29/2016 | Q216 | $0.90 | $0.71 | $1.61 billion | $1.59 billion | View | Listen | |
| 4/29/2016 | Q1 | $0.88 | $0.87 | $1.57 billion | $1.58 billion | View | Listen | |
| 2/12/2016 | Q415 | $1.06 | $1.11 | $1.39 billion | $1.37 billion | View | Listen | |
| 10/30/2015 | Q315 | $0.90 | $0.94 | $1.30 billion | $1.31 billion | View | Listen | |
| 7/31/2015 | Q215 | $0.98 | $1.00 | $1.24 billion | $1.27 billion | View | Listen | |
| 5/1/2015 | Q115 | $1.00 | $1.00 | $1.24 billion | $1.26 billion | View | Listen | |
| 2/12/2015 | Q414 | $1.01 | $1.08 | $1.25 billion | $1.26 billion | View | Listen | |
| 10/24/2014 | Q314 | $0.74 | $0.75 | $1.09 billion | $1.38 billion | View | Listen | |
| 7/25/2014 | Q214 | $0.55 | $0.84 | $1.01 billion | $1.05 billion | View | Listen | |
| 4/25/2014 | Q114 | $0.65 | $0.65 | $1,000.00 million | $1.01 billion | View | Listen | |
| 2/14/2014 | Q413 | $0.80 | $0.75 | $952.10 million | $952.60 million | View | Listen | |
| 10/25/2013 | Q313 | $0.66 | $0.68 | $891.30 million | $899.70 million | View | Listen | |
| 7/26/2013 | Q2 2013 | $0.72 | $0.65 | $911.08 million | $894.90 million | View | Listen | |
| 4/26/2013 | Q1 2013 | $0.81 | $0.69 | $924.00 million | $931.10 million | View | Listen | |
| 2/15/2013 | Q4 2012 | $0.65 | $0.76 | $863.49 million | $893.30 million | View | Listen | |
| 10/26/2012 | Q312 | $0.76 | $0.39 | $814.52 million | $820.20 million | View | N/A | |
| 7/27/2012 | | $0.80 | $0.83 | | | View | N/A | |
| 4/27/2012 | | $0.91 | $0.94 | | | View | N/A | |
| 10/28/2011 | | $0.71 | $0.77 | | | View | N/A | |
| 7/29/2011 | | $0.75 | $0.77 | | | View | N/A | |
| 4/29/2011 | | $0.81 | $0.89 | | | View | N/A | |
| 2/18/2011 | | $0.67 | $0.70 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for LifePoint Health (NASDAQ:LPNT)2017 EPS Consensus Estimate: $4.01
2018 EPS Consensus Estimate: $4.42
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 5 | $0.89 | $1.02 | $0.96 |
| Q2 2017 | 5 | $0.88 | $0.98 | $0.94 |
| Q3 2017 | 5 | $0.92 | $1.05 | $0.98 |
| Q4 2017 | 5 | $1.03 | $1.26 | $1.13 |
| Q1 2018 | 2 | $1.06 | $1.07 | $1.07 |
| Q2 2018 | 2 | $1.02 | $1.05 | $1.04 |
| Q3 2018 | 2 | $1.09 | $1.13 | $1.11 |
| Q4 2018 | 2 | $1.19 | $1.22 | $1.21 |
| Q2 2019 | 1 | $1.10 | $1.10 | $1.10 |
(Data provided by Zacks Investment Research)
Dividend History for LifePoint Health (NASDAQ:LPNT)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for LifePoint Health (NASDAQ:LPNT)Insider Ownership Percentage: 8.76%
Institutional Ownership Percentage: 99.53%
Insider Trades by Quarter for LifePoint Health (NASDAQ:LPNT)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 7/17/2017 | William F Carpenter III | Chairman | Sell | 17,653 | $65.06 | $1,148,504.18 | |
| 6/15/2017 | William F Carpenter III | Chairman | Sell | 82,347 | $64.15 | $5,282,560.05 | |
| 5/11/2017 | Richard H Evans | Director | Sell | 2,000 | $62.88 | $125,760.00 | |
| 3/30/2017 | John P Bumpus | EVP | Sell | 33,333 | $65.00 | $2,166,645.00 | |
| 3/16/2017 | David M Dill | Insider | Sell | 18,800 | $62.22 | $1,169,736.00 | |
| 3/10/2017 | David M Dill | Insider | Sell | 1,200 | $65.00 | $78,000.00 | |
| 3/9/2017 | John P Bumpus | EVP | Sell | 26,362 | $65.05 | $1,714,848.10 | |
| 3/6/2017 | John P Bumpus | EVP | Sell | 305 | $65.00 | $19,825.00 | |
| 5/25/2016 | John E D D S Maupin Jr | Director | Sell | 3,800 | $67.32 | $255,816.00 | |
| 2/18/2016 | Gregory T Bier | Director | Sell | 2,149 | $63.00 | $135,387.00 | |
| 5/7/2015 | Owen G Shell Jr | Director | Sell | 7,500 | $70.69 | $530,175.00 | |
| 3/9/2015 | John E D D S Maupin Jr | Director | Sell | 1,300 | $72.50 | $94,250.00 | |
| 2/23/2015 | Michael S Coggin | SVP | Sell | 5,000 | $70.50 | $352,500.00 | |
| 9/9/2014 | Marguerite Kondracke | Director | Sell | 1,500 | $72.43 | $108,645.00 | |
| 7/31/2014 | Leif M Murphy | CFO | Sell | 100,000 | $72.03 | $7,203,000.00 | |
| 6/12/2014 | Richard H Evans | Director | Sell | 1,000 | $64.05 | $64,050.00 | |
| 5/16/2014 | William Carpenter III | CEO | Sell | 280,849 | $58.11 | $16,320,135.39 | |
| 5/13/2014 | Paul Gilbert | EVP | Sell | 54,342 | $59.21 | $3,217,589.82 | |
| 5/7/2014 | John Bumpus | EVP | Sell | 20,000 | $57.20 | $1,144,000.00 | |
| 3/12/2014 | Marguerite Kondracke | Director | Sell | 2,000 | $51.49 | $102,980.00 | |
| 12/5/2013 | Paul Gilbert | EVP | Sell | 12,825 | $51.12 | $655,614.00 | |
| 10/31/2013 | Michael S Coggin | SVP | Sell | 2,000 | $51.14 | $102,280.00 | |
| 10/30/2013 | William F Carpenter III | CEO | Sell | 40,000 | $51.31 | $2,052,400.00 | |
| 8/1/2013 | Michael Coggin | SVP | Sell | 2,452 | $50.00 | $122,600.00 | |
| 6/6/2013 | Paul D Gilbert | EVP | Sell | 16,667 | $51.01 | $850,183.67 | |
| 5/20/2013 | Richard H Evans | Director | Sell | 4,275 | $47.50 | $203,062.50 | |
| 2/25/2013 | Michael S Coggin | SVP | Sell | 6,668 | $44.03 | $293,592.04 | |
| 2/25/2013 | Richard H Evans | Director | Sell | 5,000 | $43.31 | $216,550.00 | |
| 9/14/2012 | Marguerite Sallee | Director | Sell | 3,000 | $42.36 | $127,080.00 | |
| 8/21/2012 | Michael S Coggin | SVP | Sell | 6,666 | $41.00 | $273,306.00 | |
| 8/21/2012 | William F Carpenter III | CEO | Sell | 50,000 | $41.02 | $2,051,000.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for LifePoint Health (NASDAQ:LPNT)
Latest Headlines for LifePoint Health (NASDAQ:LPNT)
| Source: |
|
| Date | Headline |
|---|
 | Leerink Swann Comments on LifePoint Health, Inc.'s Q3 2017 Earnings (LPNT)
www.americanbankingnews.com - October 19 at 7:54 AM |
| LifePoint Health, Inc. (LPNT) Set to Announce Earnings on Thursday
www.americanbankingnews.com - October 19 at 3:18 AM |
 | ETFs with exposure to LifePoint Health, Inc. : October 17, 2017
finance.yahoo.com - October 18 at 6:42 AM |
| LifePoint Health, Inc. (LPNT) Now Covered by Analysts at BMO Capital Markets
www.americanbankingnews.com - October 16 at 6:08 PM |
| LifePoint Health To Broadcast Its Third Quarter 2017 Conference Call Live On The Internet
finance.yahoo.com - October 14 at 1:57 AM |
| LifePoint Health, Inc. (LPNT) Given a $69.00 Price Target by Robert W. Baird Analysts
www.americanbankingnews.com - October 13 at 12:32 AM |
| SunTrust Banks, Inc. Reiterates "Hold" Rating for LifePoint Health, Inc. (LPNT)
www.americanbankingnews.com - October 12 at 7:32 PM |
| LifePoint Health, Inc. (LPNT) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - October 7 at 12:38 PM |
| ETFs with exposure to LifePoint Health, Inc. : October 6, 2017
finance.yahoo.com - October 7 at 2:48 AM |
| Head-To-Head Comparison: DaVita HealthCare Partners (DVA) and LifePoint Health (LPNT)
www.americanbankingnews.com - October 6 at 2:12 PM |
| Brokerages Anticipate LifePoint Health, Inc. (LPNT) Will Post Quarterly Sales of $1.60 Billion
www.americanbankingnews.com - October 5 at 2:40 PM |
| Analyzing HealthSouth Corporation (HLS) and LifePoint Health (LPNT)
www.americanbankingnews.com - October 5 at 12:19 PM |
 | LifePoint (LPNT) Sells Unit to Focus on High-Growth Markets
www.zacks.com - October 3 at 10:08 AM |
| LifePoint Health, Inc. (LPNT) Expected to Announce Earnings of $0.96 Per Share
www.americanbankingnews.com - October 3 at 2:24 AM |
| LifePoint Health Completes Sale of Rockdale Medical Center
finance.yahoo.com - October 2 at 5:06 PM |
| LifePoint Health, Inc. breached its 50 day moving average in a Bullish Manner : LPNT-US : September 29, 2017
finance.yahoo.com - October 2 at 12:15 PM |
| ETFs with exposure to LifePoint Health, Inc. : September 26, 2017
finance.yahoo.com - September 26 at 5:52 PM |
| Should Value Investors Consider LifePoint Health (LPNT) Stock?
www.zacks.com - September 26 at 9:27 AM |
| LifePoint Health, Inc. :LPNT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 25, 2017
finance.yahoo.com - September 25 at 7:09 PM |
| Head-To-Head Contrast: LifePoint Health (LPNT) versus The Joint Corp. (JYNT)
www.americanbankingnews.com - September 23 at 2:32 PM |
| Should You Buy LifePoint Health Inc (LPNT) Now?
finance.yahoo.com - September 23 at 6:08 AM |
| Research Analysts Issue Forecasts for LifePoint Health, Inc.'s Q2 2019 Earnings (LPNT)
www.americanbankingnews.com - September 18 at 8:46 AM |
| LifePoint Health, Inc. (LPNT) Expected to Post Quarterly Sales of $1.60 Billion
www.americanbankingnews.com - September 16 at 9:11 AM |
| LifePoint Health (LPNT) versus Chemed Corp. (CHE) Critical Review
www.americanbankingnews.com - September 14 at 8:28 PM |
| LifePoint Health, Inc. (LPNT) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - September 12 at 12:48 PM |
 | LifePoint Health (LPNT) Down 4.8% Since Earnings Report: Can It Rebound?
www.nasdaq.com - September 11 at 10:52 PM |
| Comparing LifePoint Health (LPNT) and TeamHealth Holdings (TMH)
www.americanbankingnews.com - September 4 at 4:28 AM |
| Comparing LifePoint Health (LPNT) & HealthStream (HSTM)
www.americanbankingnews.com - September 1 at 12:20 PM |
| LifePoint Health to Participate in Baird 2017 Healthcare Conference
finance.yahoo.com - September 1 at 2:42 AM |
| LifePoint Health to Participate in the 2017 Wells Fargo Healthcare Conference
finance.yahoo.com - August 31 at 6:58 AM |
| Reviewing Tenet Healthcare Corporation (THC) & LifePoint Health (LPNT)
www.americanbankingnews.com - August 28 at 10:44 AM |
| Financial Contrast: American Renal Associates Holdings (ARA) and LifePoint Health (LPNT)
www.americanbankingnews.com - August 25 at 2:10 PM |
| Surprising Analyst 12-Month Target For FXH
www.nasdaq.com - August 21 at 7:40 PM |
| LifePoint Health, Inc. (LPNT) Lowered to "C+" at TheStreet
www.americanbankingnews.com - August 19 at 10:54 PM |
| Here's Why Investors Should Offload LifePoint (LPNT) Stock
www.nasdaq.com - August 19 at 2:47 AM |
| LifePoint Health, Inc. (LPNT) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - August 18 at 12:48 PM |
| $1.60 Billion in Sales Expected for LifePoint Health, Inc. (NASDAQ:LPNT) This Quarter
www.americanbankingnews.com - August 10 at 7:44 AM |
| LifePoint Health, Inc. to Post FY2018 Earnings of $4.60 Per Share, Cantor Fitzgerald Forecasts (LPNT)
www.americanbankingnews.com - August 9 at 1:42 PM |
| $0.96 Earnings Per Share Expected for LifePoint Health, Inc. (NASDAQ:LPNT) This Quarter
www.americanbankingnews.com - August 8 at 2:18 PM |
| LifePoint Health, Inc. – Value Analysis (NASDAQ:LPNT) : August 7, 2017
finance.yahoo.com - August 7 at 8:54 PM |
| Q3 2017 Earnings Estimate for LifePoint Health, Inc. Issued By KeyCorp (NASDAQ:LPNT)
www.americanbankingnews.com - August 7 at 7:40 AM |
| FY2019 Earnings Forecast for LifePoint Health, Inc. Issued By SunTrust Banks (LPNT)
www.americanbankingnews.com - August 4 at 7:40 PM |
| Leerink Swann Weighs in on LifePoint Health, Inc.'s Q3 2017 Earnings (LPNT)
www.americanbankingnews.com - August 4 at 7:16 AM |
| LifePoint Health, Inc. (NASDAQ:LPNT) Expected to Earn FY2018 Earnings of $4.50 Per Share
www.americanbankingnews.com - August 3 at 3:30 PM |
| SunTrust Banks Equities Analysts Decrease Earnings Estimates for LifePoint Health, Inc. (NASDAQ:LPNT)
www.americanbankingnews.com - August 3 at 8:00 AM |
| Research Analysts Set Expectations for LifePoint Health, Inc.'s Q3 2017 Earnings (LPNT)
www.americanbankingnews.com - August 3 at 8:00 AM |
| LifePoint Health Reports Second Quarter 2017 Results
finance.yahoo.com - August 3 at 3:30 AM |
| -Hospital operator LifePoint's quarterly profit more than doubles
finance.yahoo.com - August 3 at 3:30 AM |
| Edited Transcript of LPNT earnings conference call or presentation 1-Aug-17 2:00pm GMT
finance.yahoo.com - August 3 at 3:30 AM |
| LifePoint Health, Inc. to Post Q4 2017 Earnings of $1.03 Per Share, Oppenheimer Holdings Forecasts (LPNT)
www.americanbankingnews.com - August 2 at 1:14 PM |
LifePoint Health (LPNT) Chart for Friday, October, 20, 2017
